Join
Live feed
·
INSIDERFilingvia Quantisnow
Pandion Therapeutics Inc. logo

SEC Form 4: D. Edward Freedman decreased direct ownership by 100% to 0 units

ByQuantisnow·Wall Street's wire, on your screen.
PAND· Pandion Therapeutics Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PAND (Pandion Therapeutics Inc.) and more on Quantisnow.